These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21092888)

  • 1. "Personalizing" therapy for non-small cell lung cancer.
    D'Cunha J
    Semin Thorac Cardiovasc Surg; 2010; 22(2):118-20. PubMed ID: 21092888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular prognostication of non-small cell lung cancer.
    Tsao MS; Jablons DM
    Semin Thorac Cardiovasc Surg; 2013; 25(1):4-7. PubMed ID: 23800523
    [No Abstract]   [Full Text] [Related]  

  • 3. Prospects for molecular staging of non-small-cell lung cancer from genomic alterations.
    Tomaszek SC; Huebner M; Wigle DA
    Expert Rev Respir Med; 2010 Aug; 4(4):499-508. PubMed ID: 20658911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miRNA expression and its clinical implications for the prevention and diagnosis of non-small-cell lung cancer.
    Gao W; Xu J; Shu YQ
    Expert Rev Respir Med; 2011 Oct; 5(5):699-709. PubMed ID: 21955239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pemetrexed pathway-associated germline polymorphisms: a useful tool for treatment individualization?
    Buikhuisen WA; Burgers JA; Vincent AD; Schellens JH; Beijnen JH; Smit EF; Joerger M
    J Clin Oncol; 2010 Sep; 28(27):e482-3; author reply e484. PubMed ID: 20606096
    [No Abstract]   [Full Text] [Related]  

  • 6. Gene expression profiling of non-small-cell lung cancer.
    Lacroix L; Commo F; Soria JC
    Expert Rev Mol Diagn; 2008 Mar; 8(2):167-78. PubMed ID: 18366303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized therapy for non-small cell lung cancer: hype or clinical reality?
    Wigle DA
    Semin Thorac Cardiovasc Surg; 2011; 23(1):30-5. PubMed ID: 21807296
    [No Abstract]   [Full Text] [Related]  

  • 8. Novel therapies for non-small cell lung cancer.
    Donington JS; Koo CW; Ballas MS
    J Thorac Imaging; 2011 May; 26(2):175-85. PubMed ID: 21508738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers, prediction, and prognosis in non-small-cell lung cancer: a platform for personalized treatment.
    Sudhindra A; Ochoa R; Santos ES
    Clin Lung Cancer; 2011 Nov; 12(6):360-8. PubMed ID: 21729648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung cancer: future directions.
    Lam WK; Watkins DN
    Respirology; 2007 Jul; 12(4):471-7. PubMed ID: 17587411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic medicine in non-small cell lung cancer: paving the path to personalized care.
    Sriram KB; Larsen JE; Yang IA; Bowman RV; Fong KM
    Respirology; 2011 Feb; 16(2):257-63. PubMed ID: 21044232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 3' UTR IGF2R-A2/B2 variant is associated with increased tumor growth and advanced stages in non-small cell lung cancer.
    Kotsinas A; Evangelou K; Sideridou M; Kotzamanis G; Constantinides C; Zavras AI; Douglass CW; Papavassiliou AG; Gorgoulis VG
    Cancer Lett; 2008 Feb; 259(2):177-85. PubMed ID: 18037232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic sentinel lymph node imaging.
    Kachala SS; Servais EL; Park BJ; Rusch VW; Adusumilli PS
    Semin Thorac Cardiovasc Surg; 2009; 21(4):327-38. PubMed ID: 20226346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tissue is the issue: personalized medicine for non-small cell lung cancer.
    Hirsch FR; Wynes MW; Gandara DR; Bunn PA
    Clin Cancer Res; 2010 Oct; 16(20):4909-11. PubMed ID: 20926402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advancing personalized cancer medicine in lung cancer.
    MacConaill LE
    Arch Pathol Lab Med; 2012 Oct; 136(10):1210-6. PubMed ID: 23020726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The surgeon's role in molecular biology.
    Rocco G
    J Thorac Cardiovasc Surg; 2012 Sep; 144(3):S18-22. PubMed ID: 22739075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetic tumor markers in non-small cell lung cancer.
    Oyama T; Osaki T; Baba T; Nagata Y; Mizukami M; So T; Nakata S; Ichiki Y; Uramoto H; Sugaya M; Yoshimatsu T; Morita M; Hanagiri T; Sugio K; Kawamoto T; Yasumoto K
    Anticancer Res; 2005; 25(2B):1193-6. PubMed ID: 15865065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiling and non-small-cell lung cancer: where are we now?
    Santos ES; Blaya M; Raez LE
    Clin Lung Cancer; 2009 May; 10(3):168-73. PubMed ID: 19443336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular predictive and prognostic markers in non-small-cell lung cancer.
    Coate LE; John T; Tsao MS; Shepherd FA
    Lancet Oncol; 2009 Oct; 10(10):1001-10. PubMed ID: 19796752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular profiling of lung carcinoma: identifying clinically useful tumor markers for diagnosis and prognosis.
    Dacic S
    Expert Rev Mol Diagn; 2007 Jan; 7(1):77-86. PubMed ID: 17187486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.